Page 8 - Trepl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

…

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) has received an average rating of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued ratings on the stock in the […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Investment analysts at Wedbush issued their Q1 2024 earnings estimates for shares of Replimune Group in a research report issued on Monday, May 22nd. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.87) per share for the quarter. The consensus estimate for Replimune […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) CFO Jean M. Franchi sold 11,351 shares of the firm’s stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $18.05, for a total value of $204,885.55. Following the completion of the transaction, the chief financial officer now owns 128,748 shares […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) CEO Philip Astley-Sparke sold 17,902 shares of the stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $18.05, for a total transaction of $323,131.10. Following the completion of the transaction, the chief executive officer now directly owns 1,525,278 shares of […]